Common use of Right to Clause in Contracts

Right to. CROSS-REFERENCE IND AND EQUIVALENT FOREIGN FILINGS. ViaCell shall have the right to cross-reference Amgen's IND and equivalent foreign filings for Contributed Products solely for the purpose of Development and Commercialization of Cell Therapy Products, Collaboration Products and Unoptioned Cell Therapy Products. For the avoidance of doubt, ViaCell shall not have the right, for any reason or under any circumstance, to access, copy or review Amgen's INDs or equivalent foreign filings for Contributed Products. In the event that a Regulatory Authority requests information from ViaCell related to the manufacture or quality of Contributed Products and ViaCell is required to supply such information to the Regulatory Authority in order to pursue or maintain Regulatory Approval for a Cell Therapy Product, Collaboration Product or Unoptioned Cell Therapy, at ViaCell's request [**], Amgen shall provide the requested information by either of the following methods, as elected by Amgen [**]: (i) directly to the Regulatory Authority requesting such information; or (ii) to ViaCell, in order for ViaCell to respond to the Regulatory Authority's request in a timely manner.